Meade Christina M, Badell Martina, Hackett Stephanie, Mehta C Christina, Haddad Lisa B, Camacho-Gonzalez Andres, Ford Joy, Holstad Marcia M, Armstrong Wendy S, Sheth Anandi N
Brigham and Women's Hospital, Department of Internal Medicine, Boston MA, USA.
Emory University School of Medicine, Atlanta GA, USA.
Infect Dis Obstet Gynecol. 2019 Feb 14;2019:8161495. doi: 10.1155/2019/8161495. eCollection 2019.
INTRODUCTION: While increased healthcare engagement and antiretroviral therapy (ART) adherence occurs during pregnancy, women living with HIV (WLWH) are often lost to follow-up after delivery. We sought to evaluate postpartum retention in care and viral suppression and to identify associated factors among WLWH in a large public hospital in Atlanta, Georgia. METHODS: Data from the time of entry into prenatal care until 24 months postpartum were collected by chart review from WLWH who delivered with ≥20 weeks gestational age from 2011 to 2016. Primary outcomes were retention in HIV care (two HIV care visits or viral load measurements >90 days apart) and viral suppression (<200 copies/mL) at 12 and 24 months postpartum. Obstetric and contraception data were also collected. RESULTS: Among 207 women, 80% attended an HIV primary care visit in a mean 124 days after delivery. At 12 and 24 months, respectively, 47% and 34% of women were retained in care and 41% and 30% of women were virally suppressed. Attending an HIV care visit within 90 days postpartum was associated with retention in care at 12 months (aOR 3.66, 95%CI 1.72-7.77) and 24 months (aOR 4.71, 95%CI 2.00-11.10) postpartum. Receiving ART at pregnancy diagnosis (aOR 2.29, 95%CI 1.11-4.74), viral suppression at delivery (aOR 3.44, 95%CI 1.39-8.50), and attending an HIV care visit within 90 days postpartum (aOR 2.40, 95%CI 1.12-5.16) were associated with 12-month viral suppression, and older age (aOR 1.09, 95% CI 1.01-1.18) was associated with 24-month viral suppression. CONCLUSIONS: Long-term retention in HIV care and viral suppression are low in this population of postpartum WLWH. Prompt transition to HIV care in the postpartum period was the strongest predictor of optimal HIV outcomes. Efforts supporting women during the postpartum transition from obstetric to HIV primary care may improve long-term HIV outcomes in women.
引言:虽然孕期女性的医疗保健参与度和抗逆转录病毒疗法(ART)依从性有所提高,但感染艾滋病毒的女性(WLWH)在分娩后往往会失去随访。我们试图评估产后护理保留率和病毒抑制情况,并确定佐治亚州亚特兰大一家大型公立医院中WLWH的相关因素。 方法:通过病历审查收集了2011年至2016年孕周≥20周分娩的WLWH从进入产前护理到产后24个月的数据。主要结局是产后12个月和24个月时的艾滋病毒护理保留率(两次艾滋病毒护理就诊或病毒载量测量间隔>90天)和病毒抑制情况(<200拷贝/毫升)。还收集了产科和避孕数据。 结果:在207名女性中,80%在产后平均124天进行了艾滋病毒初级护理就诊。在产后12个月和24个月时,分别有47%和34%的女性保持在护理中,41%和30%的女性实现了病毒抑制。产后90天内进行艾滋病毒护理就诊与产后12个月(调整后比值比[aOR]3.66,95%置信区间[CI]1.72 - 7.77)和24个月(aOR 4.71,95%CI 2.00 - 11.10)的护理保留率相关。孕期诊断时接受抗逆转录病毒疗法(aOR 2.29, 95%CI 1.11 - 4.74)、分娩时病毒抑制(aOR 3.44, 95%CI 1.39 - 8.50)以及产后90天内进行艾滋病毒护理就诊(aOR 2.40, 95%CI 1.12 - 5.16)与12个月时的病毒抑制相关,而年龄较大(aOR 1.09, 95%CI 1.01 - 1.18)与24个月时的病毒抑制相关。 结论:在这群产后WLWH中,艾滋病毒护理的长期保留率和病毒抑制率较低。产后迅速过渡到艾滋病毒护理是最佳艾滋病毒治疗效果的最强预测因素。在产后从产科护理过渡到艾滋病毒初级护理期间为女性提供支持的努力可能会改善女性的长期艾滋病毒治疗效果。
Infect Dis Obstet Gynecol. 2019-2-14
AIDS Patient Care STDS. 2021-2
Front Med (Lausanne). 2025-6-27
Open Forum Infect Dis. 2025-4-9
J Acquir Immune Defic Syndr. 2025-4-15
J Am Med Inform Assoc. 2021-1-15
J Acquir Immune Defic Syndr. 2019-1-1
N Engl J Med. 2018-11-1
Obstet Gynecol. 2018-5
J Acquir Immune Defic Syndr. 2017-8-1
JAMA Pediatr. 2017-5-1